Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis

Frontiers in Microbiology
Katherine W CookBruno Gran

Abstract

Recent research has demonstrated that infection with the bacterial pathogen Helicobacter pylori is less common amongst patients with multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system (CNS). We aimed to compare the prevalence of H. pylori amongst MS patients and healthy controls, and also investigated the impact of this infection on an animal model for MS, experimental autoimmune encephalomyelitis (EAE). The H. pylori status of 71 MS patients and 42 healthy controls was determined by serology. Groups of C57BL/6 mice were infected with H. pylori, or given diluent alone as a placebo, prior to inducing EAE. Clinical scores were assessed for all mice, and spleens and spinal cord tissue were harvested. CD4(+) T cell subsets were quantified by flow cytometry, and T cell proliferation assays were performed. In MS patients the seroprevalence of H. pylori was half that of healthy controls (p = 0.018). Over three independent experiments, prior H. pylori infection had a moderate effect in reducing the severity of EAE (p = 0.012). In line with this, the antigen-specific T cell proliferative responses of infected animals were significantly reduced (p = 0.001), and there was a fourfold reduction in t...Continue Reading

References

Jul 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·J WangP B Ernst
Mar 3, 2006·The New England Journal of Medicine·Elliot M FrohmanCedric S Raine
Feb 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Dipica HaribhaiTalal A Chatila
Nov 28, 2007·Annual Review of Pathology·John C Atherton
Feb 24, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Adrian ListonShaun R McColl
May 16, 2009·Nature Reviews. Immunology·Joan Goverman
Jun 19, 2009·Journal of Neuroimmunology·Adam ElhofyWilliam J Karpus
Jun 24, 2009·The Journal of Experimental Medicine·Yuhong YangAmy E Lovett-Racke
Sep 5, 2009·The Journal of Clinical Investigation·John C Atherton, Martin J Blaser
Apr 27, 2010·Clinical and Experimental Immunology·H OkadaJ-F Bach
Jul 6, 2010·Biochimica Et Biophysica Acta·Amy E Lovett-RackeMichael K Racke
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Yun Kyung LeeSarkis K Mazmanian
Sep 18, 2010·Multiple Sclerosis : Clinical and Laboratory Research·M EdströmJ Ernerudh
Jan 22, 2011·Trends in Molecular Medicine·Bert A 't HartRobert Weissert
Mar 5, 2011·British Journal of Pharmacology·Cris S ConstantinescuBruno Gran
Mar 5, 2011·Multiple Sclerosis : Clinical and Laboratory Research·David BakerSandra Amor
Jul 9, 2011·The Journal of Clinical Investigation·Isabelle C ArnoldAnne Müller
Sep 14, 2011·FEBS Letters·A SaxenaR S Liblau
Oct 28, 2011·Nature·Kerstin BererGurumoorthy Krishnamoorthy
Aug 25, 2012·Frontiers in Cellular and Infection Microbiology·Isabelle C ArnoldAnne Müller
Dec 25, 2012·Infection and Immunity·Brian M GrayKathryn A Eaton
Jul 24, 2013·European Journal of Immunology·Heather M Grifka-WalkBenjamin M Segal
Jul 28, 2013·Neurology International·Nafiseh MohebiMehdi Moghaddasi
Sep 18, 2013·Helicobacter·Manuel KochSteven F Moss
Feb 18, 2014·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A AmberbirG Davey
Feb 28, 2014·World Journal of Gastroenterology : WJG·Daniel S SmykDimitrios P Bogdanos
Mar 15, 2014·The Journal of Infectious Diseases·Jody A WinterJohn C Atherton
Jul 10, 2014·Current Topics in Microbiology and Immunology·Maria Grazia RoncaroloManuela Battaglia

❮ Previous
Next ❯

Citations

Sep 16, 2015·Helicobacter·Francesco FranceschiJannis Kountouras
Mar 21, 2017·Annals of the New York Academy of Sciences·Antti KarkmanLasse Ruokolainen
Oct 27, 2017·Acta Neurologica Scandinavica·M Wendel-Haga, E G Celius
Mar 8, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Monica ViladomiuRaquel Hontecillas
May 31, 2018·Current Opinion in Rheumatology·Oded Shamriz, Yehuda Shoenfeld
Jan 15, 2019·Multiple Sclerosis : Clinical and Laboratory Research·Mariano MarrodanJorge Correale
Feb 6, 2020·Vaccines·Dejan JakimovskiRobert Zivadinov
Apr 8, 2020·Immunologic Research·Georgios EfthymiouDimitrios P Bogdanos
Dec 20, 2018·Frontiers in Microbiology·Davide CossuNobutaka Hattori
Aug 10, 2018·World Journal of Gastroenterology : WJG·Antonietta Gerarda GravinaMarco Romano
Jun 14, 2019·Frontiers in Cellular and Infection Microbiology·Kristin L PatrickRobert O Watson
Feb 23, 2020·Analytical Cellular Pathology (Amsterdam)·Liana SticlaruCristiana Popp
Feb 27, 2021·Frontiers in Immunology·Nina GorléRoosmarijn E Vandenbroucke
Aug 4, 2020·Journal of Translational Autoimmunity·Salvatore Cavallo

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
flow cytometry
PMA

Software Mentioned

Prism

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis